More on BCTXL
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.99 |
|
|||
| Open | $1.04 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.10 | ||||
| Day Low | $0.99 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 40,346 | ||||
- BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
- BriaCell reports extended survival in metastatic breast cancer trial
- BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
- BriaCell completes $30 million public offering of units
- BriaCell Therapeutics Announces Closing of US$30 million Public Offering
- BriaCell prices $30 million public offering at $5.59 per unit
- BriaCell Therapeutics Announces Pricing of $30 million Public Offering
Entities mentioned with BCTXL
- ThinkEquity | View Related Stories »
- S1 | View Related Stories »
- FDA | View Related Stories »
- Show More...
